PBEAT-UK: Case Management for depression and coronary heart disease

Not Applicable

Completed

Conditions: Coronary heart disease/comorbid depression
Circulatory System
Other acute ischaemic heart diseases

Registration Number: ISRCTN21615909

Lead Sponsor: King's College London (UK)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 60

Inclusion Criteria

Practices:
1. Keep a register of patients with CHD for the Quality and Outcomes Framework (QOF)
2. Willing to liaise over patients in the case management arm when necessary

Participants:
1. Symptomatic CHD as scored on the modified Rose Angina Questionnaire
2. Score greater than 9 on the Hospital Anxiety and Depression Scale (HADS)
3. Aged 16 years or over, either sex

Exclusion Criteria

Patients:
1. Temporary registrations
2. Actively suicidal or experiencing psychotic depression as evidenced by delusions and/or hallucinations
3. Under the care of secondary care mental health teams
4. Cannot speak English
5. Currently in hospital for treatment of their CHD

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Since this is a pilot study, an aim is to identify appropriate primary and secondary outcome measures. The following measures will be tested:<br>1. Depression (HADS, 9-item Patient Health Questionnaire [PHQ-9])<br>2. Coronary Heart Disease (Modified Rose Angina Questionnaire, Specific Activity Schedule)<br>3. Quality of Life (Euroqol 5D, 12-item Medical Outcomes Survey Short Form [SF-12])<br>4. Adherence to medication (Adapted version of Morisky adherence questionnaire)<br>5. Life events (List of Threatening Events Questionnaire)<br>6. Social problems (Social Problems Questionnaire)<br>7. Health Service Utilisation (Client Service Receipt Inventory (CSRI))<br>8. Illness Perceptions (Brief Illness Perceptions Questionnaire)<br>9. Participants' problem priorities (Psychlops)<br><br>Assessments will be at 1, 6 and 12 months for all outcomes.

Secondary Outcome Measures